Arthur A Levin Stoke Therapeutics, Inc. (STOK) insider trading activity

STOK Quotes by TradingView

Arthur A Levin is of Stoke Therapeutics, Inc.. Currently has a direct ownership of 2,420 shares of STOK, which is worth approximately $32,742. The most recent transaction as insider was on Jun 30, 2025, when has been sold 1,210 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.42K
100.0% 3M change
Infinity% 12M change
Total Value Held $32,742

ARTHUR A LEVIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2025
BUY
Exercise of conversion of derivative security
-
1,210 Added 33.33%
2,420 Common Stock
Mar 31 2025
BUY
Exercise of conversion of derivative security
-
1,210 Added 50.0%
1,210 Common Stock
Mar 01 2021
SELL
Open market or private sale
$760,500 $60.84 p/Share
12,500 Reduced 100.0%
0 Common Stock
Mar 01 2021
BUY
Exercise of conversion of derivative security
$5,875 $0.47 p/Share
12,500 Added 50.0%
12,500 Common Stock

Also insider at

RNA
Avidity Biosciences, Inc. Healthcare
Director
AAL

Arthur A Levin

San Diego, CA

Track Institutional and Insider Activities on STOK

Follow Stoke Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STOK shares.

Notify only if

Insider Trading

Get notified when an Stoke Therapeutics, Inc. insider buys or sells STOK shares.

Notify only if

News

Receive news related to Stoke Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on STOK